09.02.2020

CLINSPECT-M: Clinical mass spectrometry center for molecular brain research

Major project for Munich neurosciences   In a joint large-scale project, Munich scientists from proteomics, computer science and medicine investigate the causes of disorders of the central nervous system, how they can be diagnosed and how treatment response can be monitored. To this end, the Federal Ministry of Education and Research (BMBF) provides funding of 6 million euros to set up a clinical mass spectrometry center in Munich (CLINSPECT-M) for an initial period of three years.


"The goals of the project are to better diagnose severe neurological disorders, to understand their molecular causes and to monitor the course of therapy. High-performance mass spectrometry can make a decisive contribution to this", explains Prof. Bernhard Küster, professor of proteomics and bioanalysis at the Technical University of Munich (TUM) and co-spokesperson of the research consortium.

Read the TUM press release